TickerFacts.

Burning Rock Biotech Ltd (BNR): Operating Income

Annual figures by period end, from SEC filings.

-54.84M CNY
Year ended 2025-12-31
2018-12-31: -161.40M CNY2019-12-31: -169.09M CNY2020-12-31: -412.40M CNY2021-12-31: -797.06M CNY2022-12-31: -980.41M CNY2023-12-31: -669.32M CNY2024-12-31: -357.56M CNY2025-12-31: -54.84M CNY-54.84M CNY
2018-12-31 Operating Income (CNY) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-54.84M CNYn/m2026-04-28, From 2025-01-01
2024-12-31-357.56M CNYn/m2026-04-28, From 2024-01-01
2023-12-31-669.32M CNYn/m2026-04-28, From 2023-01-01
2022-12-31-980.41M CNYn/m2025-04-29, From 2022-01-01
2021-12-31-797.06M CNYn/m2024-04-29, From 2021-01-01
2020-12-31-412.40M CNYn/m2023-04-20, From 2020-01-01
2019-12-31-169.09M CNYn/m2022-04-29, From 2019-01-01
2018-12-31-161.40M CNYn/a2021-03-23, From 2018-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-31-54.84M CNYn/m
Concord Medical Services Holdings Ltd (CCM)2025-12-31-261.49M CNYn/m

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗